ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625985 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625985; 2) Community: the network communities that were significantly associated with the response to NSC 625985; 3) Molecule: the relationships between components within communities and NSC 625985; 4) MDR: the compounds that were significantly associated with the NSC 625985.

NSC Compound Enrichment Correlation
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.0385203205529754 0.53332541
NSC 609695 bis(3-chloropropyl) disulfide, S,S-dioxide 0.0385203205529754 0.66836307
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0385203205529754 0.69296913
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0385203205529754 0.54711955
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0385203205529754 0.66141225
NSC 627744 Null 0.0385203205529756 0.75380447
NSC 629868 Null 0.0385203205529756 -0.25956711
NSC 631691 Null 0.0385203205529756 -0.18182682
NSC 654379 ANTINEOPLASTIC-654379 0.0385203205529756 0.45203167
NSC 661415 2-Chloro-3-(2-butoxyethoxy)naphthazarin 0.0385203205529756 0.68497653
Total:59  Current:44    [First] [Prev] [Next] [Last]